市場調査レポート
商品コード
1423536

MCD (複数癌診断) 検査:世界市場の展望

Multi-Cancer Diagnostic Tests: Global Market Outlook

出版日: | 発行: BCC Research | ページ情報: 英文 50 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
MCD (複数癌診断) 検査:世界市場の展望
出版日: 2024年02月06日
発行: BCC Research
ページ情報: 英文 50 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のMCD (複数癌診断) 検査の市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、新興技術の動向、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

  • 市場の見通し
  • 市場サマリー

第3章 市場および技術の背景

  • バイオマーカーの種類
  • 今後の展望

第4章 市場力学

  • 市場力学のスナップショット
  • 市場促進要因
  • 癌検診におけるアンメットニーズ
  • 癌検診に対する政府の取り組み
  • 市場抑制要因
  • 偽陽性または偽陰性のリスク
  • 規制と償還の不確実性

第5章 市場内訳:テストタイプ別

  • 世界のMCD (複数癌診断) 検査市場:検査タイプ別
  • 市場規模・予測
  • ラボ開発検査
  • 体外診断検査

第6章 市場内訳:エンドユーザー別

  • 世界のMCD (複数癌診断) 検査市場:エンドユーザー別
  • 病院
  • 診断ラボ
  • 研究機関

第7章 市場内訳:地域別

  • 世界のMCD (複数癌診断) 検査市場:地域別
  • 米国
  • 欧州
  • 新興市場

第8章 新興技術

  • 起源組織の特定
  • フラグメントミクスと腫瘍教育血小板
  • 画像データ分析を伴うリキッドバイオプシー

第9章 競合情勢

  • ポーターのファイブフォース分析
  • 最近の動向
  • 臨床試験活動

第10章 企業プロファイル

  • ANCHORDX MEDICAL CO. LTD.
  • BURNING ROCK BIOTECH LTD.
  • DELFI DIAGNOSTICS
  • EXACT SCIENCES CORP.
  • FREENOME HOLDINGS INC.
  • GENECAST INC.
  • GRAIL INC.
  • GUARDANT HEALTH INC.
図表

List of Tables

  • Summary Table A : Global Multi-Cancer Diagnostic Test Market, Through 2028
  • Summary Table B : Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
  • Table 1 : Cancer Screening Guidelines
  • Table 2 : Global Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
  • Table 3 : Global Multi-Cancer Diagnostic Test Market, by Laboratory Developed Tests Type, by Region, Through 2028
  • Table 4 : Global Multi-Cancer Diagnostic Test Market, by In-Vitro Diagnostic Test Type, by Region, Through 2028
  • Table 5 : Global Multi-Cancer Diagnostic Test Market, by End User, Through 2028
  • Table 6 : Global Multi-Cancer Diagnostic Test Market Used in Hospitals, by Region, Through 2028
  • Table 7 : Global Multi-Cancer Diagnostic Test Market Used in Diagnostic Laboratories, by Region, Through 2028
  • Table 8 : Global Multi-Cancer Diagnostic Test Market Used in Research Institutions, by Region, Through 2028
  • Table 9 : Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
  • Table 10 : The U.S. Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
  • Table 11 : The U.S. Multi-Cancer Diagnostic Test Market, by End User, Through 2028
  • Table 12 : European Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
  • Table 13 : European Multi-Cancer Diagnostic Test Market, by End User, Through 2028
  • Table 14 : Emerging Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
  • Table 15 : Emerging Multi-Cancer Diagnostic Test Market, by End User, Through 2028
  • Table 16 : Emerging Multi-Cancer Diagnostic Test Market, by Country, Through 2028
  • Table 17 : Porter's Five Force Analysis of the Multi-Cancer Diagnostic Test Market
  • Table 18 : Recent Developments in Multi-Cancer Diagnostics, 2022 and 2023
  • Table 19 : Ongoing Clinical Trials for Multi-Cancer Diagnostic Tests
  • Table 20 : MCD Technologies of Competitor Products
  • Table 21 : AnchorDx Medical Co. Ltd.: Company Snapshot
  • Table 22 : Burning Rock Biotech Ltd.: Company Snapshot
  • Table 23 : Delfi Diagnostics Inc.: Company Snapshot
  • Table 24 : Exact Sciences Corp.: Company Snapshot
  • Table 25 : Freenome Holdings Inc.: Company Snapshot
  • Table 26 : Genecast Inc.: Company Snapshot
  • Table 27 : Grail Inc.: Company Snapshot
  • Table 28 : Guardant Health Inc.: Company Snapshot

List of Figures

  • Summary Figure A : Global Multi-Cancer Diagnostic Test Market, 2020-2028
  • Summary Figure B : Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
  • Figure 1 : Potential Benefits of Multi-Cancer Diagnostic Tests
  • Figure 2 : Multi-Cancer Diagnostic Tests Market Dynamics
  • Figure 3 : Evidence Generation Required for Multi-Cancer Diagnostic Tests
  • Figure 4 : Global Multi-Cancer Diagnostic Test Market, by Test Type, 2020-2028
  • Figure 5 : Global Multi-Cancer Diagnostic Test Market Share, by Test Type, 2022
  • Figure 6 : Global Multi-Cancer Diagnostic Test Market, by End User, 2020-2028
  • Figure 7 : Global Multi-Cancer Diagnostic Test Market Share, by End User, 2022
  • Figure 8 : Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
  • Figure 9 : Global Multi-Cancer Diagnostic Test Market Share, by Region, 2022
  • Figure 10 : Emerging Technologies in the Multi-Cancer Diagnosis Test Market
目次
Product Code: MDS101A

Highlights:

This report provides an in-depth analysis of the global multi-cancer diagnostic (MCD) test market. It highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products.

Report Scope:

The current report provides detailed exposure to the MCD test market and highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections for 2028. The report details the market share of MCD tests based on type and end user. The market is segmented into laboratory-developed tests and in-vitro diagnostic tests based on test type. The market is segmented into diagnostic laboratories, hospitals and research institutions based on end user. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products. The study does not include single cancer early detection tests and detection tests for targeted therapies.

The regional markets covered are U.S., Europe and emerging markets.

Revenues are broken down by region, type and end user. For market estimates, data has been provided for 2020 and 2021 as historic years, 2022 as the base year, 2023 and a forecast for 2028.

Report Includes:

  • An overview of the global market for the multi-cancer diagnostic tests
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the current and future market potential of multi-cancer detection tests along with a detailed analysis of the drivers and challenges in the market
  • Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by test type, end-user, and region
  • Overview of the significant driving trends and challenges that affect the global market and its vendor landscape
  • Discussion of sustainability trends and ESG developments in the multi-cancer diagnostic tests market, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices followed
  • Information pertaining to the recent developments and upcoming technologies in the market
  • An analysis of the market competitive landscape featuring the company revenue share analyses, recent mergers and acquisition activities, and venture funding outlook
  • Company profiles of the major global players

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of the Report
  • Methodology
  • Information Sources
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Market Summary

Chapter 3 Market and Technology Background

  • Introduction
  • Types of Biomarkers
  • Future Outlook

Chapter 4 Market Dynamics

  • Market Dynamics Snapshot
  • Market Drivers
  • Unmet Needs in Cancer Screening
  • Government Measures for Cancer Screening
  • Market Restraints
  • Risk of False Positives or False Negatives
  • Regulatory and Reimbursement Uncertainty

Chapter 5 Market Breakdown by Test Type

  • Global Multi-Cancer Diagnostic Test Market, by Test Type
  • Market Size and Forecast
  • Laboratory Developed Tests
  • In-Vitro Diagnostic Tests

Chapter 6 Market Breakdown by End User

  • Global Multi-Cancer Diagnostic Test Market, by End User
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions

Chapter 7 Market Breakdown by Region

  • Global Multi-Cancer Diagnostic Test Market, by Region
  • The U.S.
  • Europe
  • Emerging Markets

Chapter 8 Emerging Technologies

  • Introduction
  • Identification of Tissue of Origin
  • Fragmentomics and Tumor-Educated Platelets
  • Liquid Biopsy with Imaging Data Analysis

Chapter 9 Competitive Landscape

  • Porter's Five Forces Analysis
  • Threat of New Entrants
  • Threat of Substitutes
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Degree of Competition
  • Recent Developments in the Multi-Cancer Diagnostic Market
  • Clinical Trial Activities

Chapter 10 Company Profiles

  • ANCHORDX MEDICAL CO. LTD.
  • BURNING ROCK BIOTECH LTD.
  • DELFI DIAGNOSTICS
  • EXACT SCIENCES CORP.
  • FREENOME HOLDINGS INC.
  • GENECAST INC.
  • GRAIL INC.
  • GUARDANT HEALTH INC.